AI genome sequencing could transform rare disease diagnosis: GeneDx CEO

Name: AI genome sequencing could transform rare disease diagnosis: GeneDx CEO
Uploaded: 2026-01-12T15:26:16Z
Duration: 5 min 44 s
Description: GeneDx CEO Katherine Stueland discusses the company’s AI-driven partnership with Komodo Health, the push to speed rare disease diagnosis and GeneDx’s accelerating growth outlook.

FBN · Jan 12, 2026 · 5m 44sSign Up Now

Already a subscriber?

GeneDx CEO Katherine Stueland discusses the company’s AI-driven partnership with Komodo Health, the push to speed rare disease diagnosis and GeneDx’s accelerating growth outlook.